DOI: https://doi.org/10.22141/2224-0551.6.66.2015.74949

The Use of Linezolid in Children with Malignant Solid Tumors

H.I. Klymniuk, S.V. Pavlyk, O.V. Shaida, O.Y. Izhovskyi, O.V. Bilokon

Abstract


In recent decades, in the treatment of cancer there has been achieved a significant success not only by the introduction of cancer treatment protocol, but mostly due to the planned combination concomitant treatment of infectious complications. The need for antimicrobial agents against resistant Gram-positive bacteria, such as methicillin-resistant staphylococci, penicillin-resistant pneumococci, vancomycin-resistant enterococci, has significantly increased. In the department of pediatric oncology of the National cancer institute (Kyiv), linezolid preparations were used in children with infection of soft tissues and bones, febrile neutropenia and for the treatment of severe cases of sepsis. Experience of Linelid® use in the department of pediatric oncology of the National cancer institute indicates its effectiveness, safety and good tolerance in children with malignant solid tumors.

References


Дяченко В.В. Линезолид в клинической практике // Therapia. — 2013. — № 1(76).

Kaplan S.L., Afghani B., Lopez P. et al. Linezolid for the treatment of methicillin-resistant Staphylococcus aureus infections in children // Pediatr. Infect. Dis. J. — 2003. — Vol. 22(9 Suppl.). — S178-85.

Balk R.A., Casey L.C. // Critical Care Clinics. — 2000. — № 4. — Р. 1240-1243.

Буслаева Г.Н. // Педиатрия. — 2005. — № 2. — С. 75-79.

Deville J.G., Adler S., Azimi P.H. et al. // Pediatr. Iinfect. Dis. J. — 2003. — Vol. 22. — S158-163.

Dong F., Yao B., Wang J., Jing H.M., Ke X.Y. Distribution characteristics and antimicrobial resistance of pathogens about hospital infection from patients in single hematology center during 2011 and 2013 // Beijing Da Xue Xue Bao. — 2015 Jun 18. — Vol. 47(3). — P. 499-503.

Lopez-Garcia B., Luque S., Roberts J.A., Grau S.J. Pharmacokinetics and preliminary safety of high dose linezolid for the treatment of Gram-Positive bacterial infections // J. Infect. Dis. — 2015 Jun 19. — pii: S0163-4453.

Averbuch D., Orasch C., Cordonnier C. European guidelines for empirical antibacterial therapy for febrile neutropenic patients in the era of growing resistance: summary of the 2011 4th European Conference on Infections in Leukemia // Haematologica. — 2013 December. — Vol. 98. — P. 1826-1835.




Copyright (c) 2016 CHILD`S HEALTH

Creative Commons License
This work is licensed under a Creative Commons Attribution 4.0 International License.

 

© Publishing House Zaslavsky, 1997-2018

 

   Seo анализ сайта